Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07543367 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Study sites: 4 to 5v3 Show 1 more changeShow less
    • Study sites: 4 to 5
  2. Primary endpoint(s) modified Phase changed: not specified → not applicable · Sponsor changed: [Redacted] to Synchron, Inc. · Trial status changed: Withheld → Not Yet Recruiting · 7 morev2 Show 10 more changesShow less
    • Phase changed: not specified → not applicable
    • Sponsor changed: [Redacted] to Synchron, Inc.
    • Trial status changed: Withheld → Not Yet Recruiting
    • Enrollment changed: None → 10
    • Trial sites expanded: 0 → 4 locations
    • Trial arms changed: 0 → 1
    • Primary completion date: Jun 2027
    • Completion date: Dec 2029
    • Start date: Apr 2026
    • Study title shortened, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Synchron, Inc.
3 trials monitored
See all monitored trials
ALS
387 trials monitored
See 18 trials at risk
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Trial Details
NCT Number NCT07543367
Lead Sponsor Synchron, Inc.
Conditions Neurological Disorder, ALS (Amyotrophic Lateral Sclerosis), Motor Neuron Disease, ALS - Amyotrophic Lateral Sclerosis, ALS
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov